A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

19 Nov 2024

J-Y Blay, C Schiffler, O Bouché, M Brahmi, F Duffaud, M Toulmonde, B Landi, W Lahlou, D Pannier, E Bompas, F Bertucci, L Chaigneau, O Collard, M Pracht, C Henon, I Ray-Coquard, K Armoun, S Salas, M Spalato-Ceruso, A Adenis, B Verret, N Penel, C Moreau-Bachelard, A Italiano, A Dufresne, S Metzger, S Chabaud, D Perol, A Le Cesne

Annals of Oncology, 2024 Sep.

Abstract link

Forse può anche interessarti